Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment

Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous cath...

Descripción completa

Detalles Bibliográficos
Autores principales: Appel-da-Silva, Marcelo C., Narvaez, Gabriel A., Perez, Leandro R.R., Drehmer, Laura, Lewgoy, Jairo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537395/
https://www.ncbi.nlm.nih.gov/pubmed/28794958
http://dx.doi.org/10.1016/j.mmcr.2017.07.007
Descripción
Sumario:Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous catheter during treatment of antibiotic-associated pseudomembranous colitis with the probiotic Saccharomyces cerevisiae var. boulardii. Fungemia was resolved after interruption of probiotic administration without the need to replace the central venous line.

Ejemplares similares